Legal status · United States
Is Elamipretide legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Elamipretide is an approved medicine in the United States. Its legal category is "FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 5 completed human trials are cited on its profile.
- People given it
- 487
- Found nothing
- 3
Legal category
FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational
FDA approval and compounding status, from the Elamipretide profile.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
Elamipretide in the United States at a glance
| Legal category | FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational |
|---|---|
| FDA approval status | FDA-approved September 19, 2025 as Forzinity for Barth syndrome, a rare inherited disease. It was an early, conditional (accelerated) approval. Other uses are investigational |
| Studies in people | 5 of 7 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the Elamipretide profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.
What this means
- 01
FDA has approved Elamipretide for at least one use named on its label. So a proper pharmacy-grade product exists in the United States, and pharmacies hand it out on prescription.
- 02
Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.
- 03
Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.
What Elamipretide is
Approved in 2025 for one rare genetic disease, Barth syndrome, on a result its own main study missed. In a large final-stage study in an inherited muscle disease, it clearly did not help.
Elamipretide goes to the inner wall of mitochondria, the power plants in your cells. It sticks to a fat there called cardiolipin.
How it works: It sticks to cardiolipin, a fat in the inner wall of mitochondria. That helps hold the folds of the wall in shape, so the cell's power plant makes energy (ATP) better.
Approval history: FDA-approved September 19, 2025 as Forzinity for Barth syndrome, a rare inherited disease. It was an early, conditional (accelerated) approval. Other uses are investigational
How FDA treats this kind of product
Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.
The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for Elamipretide on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
Elamipretide in sport and the military
Whether Elamipretide is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up Elamipretide by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
Elamipretide in other countries
Frequently asked questions
Is Elamipretide legal in the United States?
Yes. Elamipretide is an approved medicine in the United States. Its legal category is "FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 5 completed human trials are cited on its profile.
Can I buy Elamipretide in the United States?
Only with a prescription. In the United States, Elamipretide has the legal category "FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives.
Is Elamipretide FDA approved?
Yes. FDA status: FDA-approved September 19, 2025 as Forzinity for Barth syndrome, a rare inherited disease. It was an early, conditional (accelerated) approval. Other uses are investigational. Current US legal category: "FDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational". On the evidence, 5 completed human trials are cited on its profile.
Related compounds in the United States
Full research profile
How Elamipretide works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
Elamipretide profileThis page is general information about the legal status of Elamipretide in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.